BRN.AX stock trades at A$0.14 intraday on 28 Feb 2026, with volume at 13,769,277 shares and a tight intraday range of A$0.13–A$0.145. The company, BrainChip Holdings Ltd (ASX), sells the Akida neuromorphic processor aimed at ultra‑low power AI at the edge. Investors are watching the upcoming earnings date of 4 March 2026 for revenue cadence and new design‑win updates that could move the share price.

Market snapshot and intraday flow for BRN.AX stock

BrainChip (BRN.AX) shows market cap of A$365.56M and shares outstanding of 2,358,458,279. The stock opened at A$0.135 and is trading near prior close A$0.14. Volume is high versus average at a relative volume of 1.54.

Short-term price context: the 50‑day average is A$0.16 and the 200‑day average is A$0.19, positioning the stock below medium and long moving averages.

Why AI edge hardware matters for BRN.AX stock

BrainChip targets low‑power edge AI with its Akida neuromorphic SoC and development tools. Demand in automotive and cybersecurity provides addressable markets that reward power efficiency. The business model depends on design wins and scale in semiconductors.

For investors this means revenue timing and partner certifications drive binary share moves rather than steady recurring revenue.

Financials, valuation and BRN.AX stock metrics

Recent reported EPS is -0.02 and headline PE reads -7.75, reflecting negative earnings. Key ratios show a strong liquidity buffer with current ratio 5.18 and cash per share A$0.0065. Price to book is elevated at 15.06, and price to sales is 197.93, signalling high valuation versus trailing revenues.

Revenue grew 71.55% in FY2024 but margins remain negative with net margin around -16.94%. Investors should weigh growth versus steep valuation multiples in a capital‑intensive AI hardware path.

Technical indicators and trading signals for BRN.AX stock

Momentum indicators show RSI 56.42 and ADX 36.17, implying a reasonably strong recent trend. Bollinger bands sit at 0.12–0.16 with ATR A$0.01, so daily moves remain small in dollar terms but significant in percent.

Short‑term traders will watch support near A$0.13 and resistance near the 50‑day A$0.16. CCI at 127.85 flags short‑term overbought conditions, increasing the chance of a pullback.

Meyka AI rates BRN.AX with a score out of 100 and outlook

Meyka AI rates BRN.AX with a score out of 100: 64.82 / 100, Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects A$0.15 in one year and A$0.09 in three years. Compared with the current price A$0.14, the one‑year projection implies an upside of 7.14%. Forecasts are model‑based projections and not guarantees.

Risks, catalysts and sector context for BRN.AX stock

Primary risks include continued negative earnings, high valuation versus revenue, and slow semiconductor adoption cycles. Company specific risks include product certification delays and supply constraints.

Catalysts that could lift the stock: positive FY earnings on 4 March 2026, new design wins, or meaningful revenue bookings. The Technology sector has underperformed recently, which can amplify moves in small AI hardware names.

Final Thoughts

Key takeaways for BRN.AX stock: BrainChip trades at A$0.14 with a market cap of A$365.56M and elevated volatility on news. Fundamentals show revenue growth but persistent losses and high valuation ratios such as price‑to‑sales 197.93 and price‑to‑book 15.06. Technicals give short resistance at A$0.16 and support at A$0.13. Meyka AI’s view is measured: Meyka AI rates BRN.AX with a score out of 100 at 64.82 (Grade B, HOLD). Meyka AI’s forecast model projects A$0.15 in one year, implying a 7.14% upside from today’s price of A$0.14. Forecasts are model‑based projections and not guarantees. Investors should treat BRN.AX as a news‑driven, speculative AI hardware play and size positions accordingly. For immediate traders, watch the earnings release on 4 March 2026 and any partner announcements that validate Akida adoption. Meyka AI provides this as an AI‑powered market analysis platform insight and not personal financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.